Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Rosenkranz

Showing results (31-40 of 277) with videos related to

Pageof 28
Sort By:
Pulmonary Circulation|February 16, 2019
High-risk pregnancy in a patient with pulmonary arterial hypertension due to congenital heart disease (PAH-CHD) with temporary shunt inversion and deoxygenationChristopher Hohmann, Daniel Dumitrescu, Felix Gerhardt, et al.
Life Sciences|November 22, 2005
Phosphodiesterase type 5 inhibitor sildenafil citrate does not potentiate the vasodilative properties of nebivolol in rat aortaStephan Rosenkranz, Klara Brixius, René Halbach, et al.
BMC Pulmonary Medicine|January 30, 2016
Case report: Subjective loss of performance after pulmonary embolism in an athlete- beyond normal valuesDaniel Dumitrescu, Felix Gerhardt, Thomas Viethen, et al.
Heart Failure Clinics|July 4, 2018
Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension: Controversies and Practical IssuesMichele D'Alto, Konstantinos Dimopoulos, John Gerard Coghlan, et al.
AIDS (London, England)|April 20, 2004
Ritonavir exhibits anti-atherogenic properties on vascular smooth muscle cellsKai Kappert, Evren Caglayan, Anselm T Bäumer, et al.
FEBS Letters|December 5, 2006
PI3-kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Src family kinasesMarius Vantler, Michael Huntgeburth, Evren Caglayan, et al.
Expert Opinion on Investigational Drugs|November 15, 2011
Imatinib mesylate for the treatment of pulmonary arterial hypertensionHenrik ten Freyhaus, Daniel Dumitrescu, Eva Berghausen, et al.
European Journal of Heart Failure|August 15, 2017
What can we learn from pulmonary function testing in heart failure?Helgo Magnussen, Marco Canepa, Peter Emilio Zambito, et al.
Clinical Drug Investigation|September 22, 2018
Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT)Michael Huntgeburth, Johannes Kießling, Gerrit Weimann, et al.
Deutsches Arzteblatt International|March 1, 2017
Pulmonary HypertensionMarius M Hoeper, Hossein-Ardeschir Ghofrani, Ekkehard Grünig, et al.
Pageof 28

Showing results (31-40 of 277) with videos related to

Sort By:
Pageof 28
Pulmonary Circulation|February 16, 2019
High-risk pregnancy in a patient with pulmonary arterial hypertension due to congenital heart disease (PAH-CHD) with temporary shunt inversion and deoxygenationChristopher Hohmann, Daniel Dumitrescu, Felix Gerhardt, et al.
Life Sciences|November 22, 2005
Phosphodiesterase type 5 inhibitor sildenafil citrate does not potentiate the vasodilative properties of nebivolol in rat aortaStephan Rosenkranz, Klara Brixius, René Halbach, et al.
BMC Pulmonary Medicine|January 30, 2016
Case report: Subjective loss of performance after pulmonary embolism in an athlete- beyond normal valuesDaniel Dumitrescu, Felix Gerhardt, Thomas Viethen, et al.
Heart Failure Clinics|July 4, 2018
Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension: Controversies and Practical IssuesMichele D'Alto, Konstantinos Dimopoulos, John Gerard Coghlan, et al.
AIDS (London, England)|April 20, 2004
Ritonavir exhibits anti-atherogenic properties on vascular smooth muscle cellsKai Kappert, Evren Caglayan, Anselm T Bäumer, et al.
FEBS Letters|December 5, 2006
PI3-kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Src family kinasesMarius Vantler, Michael Huntgeburth, Evren Caglayan, et al.
Expert Opinion on Investigational Drugs|November 15, 2011
Imatinib mesylate for the treatment of pulmonary arterial hypertensionHenrik ten Freyhaus, Daniel Dumitrescu, Eva Berghausen, et al.
European Journal of Heart Failure|August 15, 2017
What can we learn from pulmonary function testing in heart failure?Helgo Magnussen, Marco Canepa, Peter Emilio Zambito, et al.
Clinical Drug Investigation|September 22, 2018
Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT)Michael Huntgeburth, Johannes Kießling, Gerrit Weimann, et al.
Deutsches Arzteblatt International|March 1, 2017
Pulmonary HypertensionMarius M Hoeper, Hossein-Ardeschir Ghofrani, Ekkehard Grünig, et al.
Pageof 28